Acute upper limb ischemia in a patient with COVID-19

Parminder Kaur, Firas Qaqa, Amr Ramahi, Yezin Shamoon, Monisha Singhal, Fayez Shamoon, Michael Maroules, Balraj Singh, Parminder Kaur, Firas Qaqa, Amr Ramahi, Yezin Shamoon, Monisha Singhal, Fayez Shamoon, Michael Maroules, Balraj Singh

Abstract

Patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection mainly present with upper and lower respiratory tract symptoms, with complications related to cytokine storm syndrome and acute respiratory distress syndrome. It has also been described to predispose to venous and arterial thromboembolism; however, limited published data is available regarding thrombosis in coronavirus disease 2019 (COVID-19). Here we are presenting a case of arterial thrombosis in a patient with COVID-19 and a systematic review on coagulopathy associated with COVID-19.

Keywords: Acute limb ischemia; Arterial thrombosis; COVID-19; Severe acute respiratory syndrome coronavirus 2.

© 2020 King Faisal Specialist Hospital & Research Centre. Published by Elsevier Ltd.

Figures

Fig. 1
Fig. 1
Computed tomography (CT) with angiogram showing filling defects; Purple arrow indicates absent flow in the right axillary artery; blue arrow indicates reconstituted flow in the diminutive brachial artery; and red arrow indicates incomplete visualization of the distal ulnar artery.

References

    1. World Health Organization (WHO). WHO Director-General's remarks at the media briefing on 2019-nCoV on 11 February 2020. Geneva, Switzerland: WHO; 2020. Available from: (accessed 6 May 2020).
    1. Lu R., Zhao X., Li J., Niu P., Yang B., Wu H., et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet. 2020;395:565–574.
    1. Wu Z., Mcgoogan J.M. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China. JAMA. 2020;323:1239.
    1. Xiong M., Liang X., Wei Y.D. Changes in blood coagulation in patients with severe coronavirus disease 2019 (COVID‐19): a meta‐analysis. Br J Haematol. 2020 doi: 10.1111/bjh.16725. Submitted for publication.
    1. Tang N., Li D., Wang X., Sun Z. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost. 2020;18:844–847.
    1. Cui S., Chen S., Li X., Liu S., Wang F. Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia. J Thromb Haemost. 2020 doi: 10.1111/jth.14830. Submitted for publication.
    1. Klok F.A., Kruip M.J.H.A., van der Meer N.J.M., Arbous M.S., Gommers D.A.M.P.J., Kant K.M., et al. Confirmation of the high cumulative incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thromb Res. 2020 doi: 10.1016/j.thromres.2020.04.041. in press.
    1. Gralinski L.E., Sheahan T.P., Morrison T.E., Menachery V.D., Jensen K., Leist S.R., et al. Complement activation contributes to severe acute respiratory syndrome coronavirus pathogenesis. Mbio. 2018;9:e01753–18.
    1. Jiang Y., Zhao G., Song N., Li P., Chen Y., Guo Y., et al. Blockade of the C5a–C5aR axis alleviates lung damage in hDPP4-transgenic mice infected with MERS-CoV. Emerg Microbes Infect. 2018;7:77.
    1. Campbell C.M., Kahwash R. Will complement inhibition be the new target in treating COVID-19 related systemic thrombosis? Circulation. 2020 doi: 10.1161/CIRCULATIONAHA.120.047419. in press.

Source: PubMed

Sponsors et collaborateurs

Les conditions médicales

Interventions en matière de drogue

3
S'abonner